...
机译:组胺H3受体配体改善药物相似性的苄基哌啶变化
Johann Wolfgang Goethe University Institute of Pharmaceutical Chemistry Biozentrum Max-von-Laue;
Heinrich Heine University Duesseldorf Institute of Pharmaceutical and Medicinal Chemistry;
Johann Wolfgang Goethe University Institute of Pharmaceutical Chemistry Biozentrum Max-von-Laue;
Johann Wolfgang Goethe University Institute of Pharmaceutical Chemistry Biozentrum Max-von-Laue;
Heinrich Heine University Duesseldorf Institute of Pharmaceutical and Medicinal Chemistry;
Johann Wolfgang Goethe University Institute of Pharmaceutical Chemistry Biozentrum Max-von-Laue;
Heinrich Heine University Duesseldorf Institute of Pharmaceutical and Medicinal Chemistry;
Antagonists; Drug-likeness; GPCR; Lipophilicity;
机译:组胺H3受体配体改善药物相似性的苄基哌啶变化
机译:2-氨基嘧啶作为组胺H3受体配体的药物似方法
机译:新型杂环取代的苯并呋喃组胺H3受体拮抗剂:体外特性,药物样和行为活性。
机译:解开组胺受体HI,H 2,H3和H4在犬胃肠道中的作用
机译:组胺H3受体在皮肤和脊髓中的定位和抗伤害感受性。
机译:2-氨基嘧啶作为组胺H3受体配体的药物似方法
机译:组胺H3受体的配体调节大鼠氧化性粘膜中的细胞增殖和迁移